Zepbound® & Mounjaro® in Tampa , FL
Meet with an Oceans provider to discuss whether an FDA-approved tirzepatide medication may be appropriate for your medical needs. Zepbound® and Mounjaro® contain tirzepatide, but they have different FDA-approved uses.
Dual GIP and GLP-1 Treatment
Tirzepatide acts on both GIP and GLP-1 pathways involved in appetite, food intake, and blood-sugar regulation. A provider should determine which product, if either, matches your diagnosis, medical history, goals, and coverage.
Appetite Support
Tirzepatide may help eligible patients manage appetite, portion size, and food intake.
Once-Weekly Injection
Both products are generally administered once weekly according to product-specific dosing instructions.
Clinical Monitoring
Follow-up may include dose review, side-effect monitoring, progress assessment, and laboratory testing when indicated.
How to Get Started
What Is the Difference?
Both products contain tirzepatide, but the prescribed brand should match the patient’s diagnosis, clinical needs, product labeling, and insurance coverage.
Zepbound®
- FDA-approved for chronic weight management in eligible adults
- Used with a reduced-calorie diet and increased physical activity
- Also approved for moderate-to-severe obstructive sleep apnea in certain adults with obesity
- Eligibility depends on diagnosis, health history, and provider evaluation
Mounjaro®
- FDA-approved to improve blood-sugar control in adults with type 2 diabetes
- Used together with diet and exercise
- Not FDA-approved specifically as a weight-loss medication
- Prescription and dosing require provider supervision
Medication availability, insurance coverage, prior authorization, out-of-pocket cost, and pharmacy supply can vary. Confirm current options with Oceans during your consultation.
Your Treatment Plan May Include
Medication is only one part of sustainable medical weight management. Your provider may recommend a broader plan based on your health and goals.
Zepbound® & Mounjaro® FAQ
Are Zepbound® and Mounjaro® the same medication?
They contain the same active ingredient, tirzepatide, but have different FDA-approved indications and product labeling.
Is Mounjaro® approved for weight loss?
Mounjaro® is FDA-approved for adults with type 2 diabetes. Zepbound® is the tirzepatide brand approved for chronic weight management in eligible patients.
How often are they administered?
Both are generally administered once weekly. Follow only the dosing instructions for the product prescribed to you.
What side effects can occur?
Common effects may include nausea, vomiting, diarrhea, constipation, abdominal discomfort, reduced appetite, or indigestion. Serious adverse effects may also occur.
Will insurance cover Zepbound® or Mounjaro®?
Coverage varies by diagnosis, plan benefits, prior authorization rules, and formulary. Contact your insurer and confirm current options with Oceans.
Can I use Zepbound® and Mounjaro® together?
No. These products contain the same active ingredient and should not be used together. Follow your provider’s medication instructions.
Discuss Zepbound® or Mounjaro® With Oceans
Meet with a provider in Tampa to review your diagnosis, eligibility, treatment goals, medication availability, and coverage options.
Book an AppointmentZepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Oceans Weight Loss & Med Spa is not represented as affiliated with or endorsed by Eli Lilly. Prescription treatment requires a medical evaluation and is provided only when clinically appropriate. Results vary. This page is for general education and does not replace individualized medical advice.
Online Follow-Up Appointments Available
Sometimes there are obstacles to coming into a medical office, but help is still available. Our doctors can meet you over a HIPAA compliant connection for any services, many same day follow up appointments available!